Telix Pharmaceuticals (TLX) Current Taxes (2023 - 2025)

Telix Pharmaceuticals (TLX) has disclosed Current Taxes for 3 consecutive years, with $30.7 million as the latest value for Q4 2025.

  • Quarterly Current Taxes fell 3.23% to $30.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.7 million through Dec 2025, down 3.23% year-over-year, with the annual reading at $30.7 million for FY2025, 2.18% up from the prior year.
  • Current Taxes for Q4 2025 was $30.7 million at Telix Pharmaceuticals, down from $31.8 million in the prior quarter.
  • The five-year high for Current Taxes was $31.8 million in Q4 2024, with the low at $12.5 million in Q4 2023.
  • Average Current Taxes over 3 years is $25.0 million, with a median of $30.7 million recorded in 2025.
  • The sharpest move saw Current Taxes skyrocketed 154.64% in 2024, then dropped 3.23% in 2025.
  • Over 3 years, Current Taxes stood at $12.5 million in 2023, then surged by 154.64% to $31.8 million in 2024, then fell by 3.23% to $30.7 million in 2025.
  • According to Business Quant data, Current Taxes over the past three periods came in at $30.7 million, $31.8 million, and $12.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.